TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.